Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response: Progress, Achievements, and the Future
While the exact proprietary blend may vary, its core components typically aim to support functions such as tissue regeneration, anti-inflammatory processes, and overall systemic resilience [1]
United Healthcare, for example, typically covers it with prior authorization for BMI of 30 or higher, or a BMI of 27 with related health issues
Phase 3 trials are ongoing, and without completed large-scale safety and efficacy data, the compound cannot be considered ready for routine clinical use